BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 34567162)

  • 1.
    Memar MY; Adibkia K; Farajnia S; Samadi Kafil H; Khalili Y; Azargun R; Ghotaslou R
    Iran J Pharm Res; 2021; 20(2):286-296. PubMed ID: 34567162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro synergy of antibiotic combinations against planktonic and biofilm Pseudomonas aeruginosa.
    Ghorbani H; Memar MY; Sefidan FY; Yekani M; Ghotaslou R
    GMS Hyg Infect Control; 2017; 12():Doc17. PubMed ID: 29094001
    [No Abstract]   [Full Text] [Related]  

  • 3. Mathematical pharmacodynamic modeling for antimicrobial assessment of ceftazidime/colistin versus gentamicin/meropenem combinations against carbapenem-resistant Pseudomonas aeruginosa biofilm.
    Badawy MSEM; Elkhatib WF; Shebl RI
    Ann Clin Microbiol Antimicrob; 2023 Jul; 22(1):53. PubMed ID: 37394468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Vitro Antibiofilm Activity of Fosfomycin Alone and in Combination with Other Antibiotics against Multidrug-Resistant and Extensively Drug-Resistant
    Slade-Vitković M; Batarilo I; Bielen L; Maravić-Vlahoviček G; Bedenić B
    Pharmaceuticals (Basel); 2024 Jun; 17(6):. PubMed ID: 38931436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of fosfomycin-gentamicin, fosfomycin-ceftazidime, fosfomycin-imipenem and ceftazidime-gentamicin combinations against ceftazidime-resistant Pseudomonas aeruginosa.
    Pruekprasert P; Tunyapanit W
    Southeast Asian J Trop Med Public Health; 2005 Sep; 36(5):1239-42. PubMed ID: 16438151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of colistin or sulbactam in combination with fosfomycin or imipenem against clinical isolates of carbapenem-resistant Acinetobacter baumannii producing OXA-23 carbapenemases.
    Santimaleeworagun W; Wongpoowarak P; Chayakul P; Pattharachayakul S; Tansakul P; Garey KW
    Southeast Asian J Trop Med Public Health; 2011 Jul; 42(4):890-900. PubMed ID: 22299471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An experimental study to evaluate the effect of polymixin E (Colistin) alone or in combination with gentamicin in McCarey-Kaufman corneal preservation medium on various drug resistant bacterial and fungal isolates.
    Sushmasri K; Joseph J; Chaurasia SR; Ramachandran C; Roy S
    Indian J Ophthalmol; 2022 Aug; 70(8):2950-2955. PubMed ID: 35918951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of fosfomycin in combination with colistin against clinical isolates of carbapenem-resistant Pseudomas aeruginosa.
    Di X; Wang R; Liu B; Zhang X; Ni W; Wang J; Liang B; Cai Y; Liu Y
    J Antibiot (Tokyo); 2015 Sep; 68(9):551-5. PubMed ID: 25805069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activities of carbapenems in combination with amikacin, colistin, or fosfomycin against carbapenem-resistant Acinetobacter baumannii clinical isolates.
    Singkham-In U; Chatsuwan T
    Diagn Microbiol Infect Dis; 2018 Jun; 91(2):169-174. PubMed ID: 29433997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro susceptibility pattern of cephalosporin-resistant Gram-negative bacteria.
    Punpanich W; Tantichattanon W; Wongwatcharapaiboon S; Treeratweeraphong V
    J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S21-7. PubMed ID: 19255989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibacterial and anti-biofilm activities of melittin and colistin, alone and in combination with antibiotics against Gram-negative bacteria.
    Dosler S; Karaaslan E; Alev Gerceker A
    J Chemother; 2016 Apr; 28(2):95-103. PubMed ID: 25801062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro antibacterial activity of rifampicin in combination with imipenem, meropenem and doripenem against multidrug-resistant clinical isolates of Pseudomonas aeruginosa.
    Hu YF; Liu CP; Wang NY; Shih SC
    BMC Infect Dis; 2016 Aug; 16(1):444. PubMed ID: 27553962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial effects of Melaleuca alternifolia (tea tree) essential oil against biofilm-forming multidrug-resistant cystic fibrosis-associated Pseudomonas aeruginosa as a single agent and in combination with commonly nebulized antibiotics.
    Haines RR; Putsathit P; Tai AS; Hammer KA
    Lett Appl Microbiol; 2022 Sep; 75(3):578-587. PubMed ID: 34687564
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Soudeiha MAH; Dahdouh EA; Azar E; Sarkis DK; Daoud Z
    Front Cell Infect Microbiol; 2017; 7():209. PubMed ID: 28596943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of fosfomycin/colistin combinations against planktonic and biofilm Gram-negative pathogens.
    Boncompagni SR; Micieli M; Di Maggio T; Aiezza N; Antonelli A; Giani T; Padoani G; Vailati S; Pallecchi L; Rossolini GM
    J Antimicrob Chemother; 2022 Jul; 77(8):2199-2208. PubMed ID: 35512342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of synergism between colistin, fosfomycin and tigecycline against extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates or with carbapenem resistance.
    Ku YH; Chen CC; Lee MF; Chuang YC; Tang HJ; Yu WL
    J Microbiol Immunol Infect; 2017 Dec; 50(6):931-939. PubMed ID: 28716360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic Activity of Fosfomycin, Ciprofloxacin, and Gentamicin Against
    Wang L; Di Luca M; Tkhilaishvili T; Trampuz A; Gonzalez Moreno M
    Front Microbiol; 2019; 10():2522. PubMed ID: 31781056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial susceptibility of multidrug-resistant Pseudomonas aeruginosa isolated from drinking water and hospitalized patients in Jordan.
    Tarazi YH; Abu-Basha E; Ismail ZB; Al-Jawasreh SI
    Acta Trop; 2021 May; 217():105859. PubMed ID: 33582141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vitro activities of imipenem-colistin, imipenem-tigecycline, and tigecycline-colistin combinations against carbapenem-resistant Enterobacteriaceae.
    Dundar D; Duymaz Z; Genc S; Er DK; İrvem A; Kandemir N
    J Chemother; 2018; 30(6-8):342-347. PubMed ID: 30663555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of fosfomycin combined with other antimicrobial agents against multidrug-resistant Pseudomonas aeruginosa isolates using the efficacy time index assay.
    Okazaki M; Suzuki K; Asano N; Araki K; Shukuya N; Egami T; Higurashi Y; Morita K; Uchimura H; Watanabe T
    J Infect Chemother; 2002 Mar; 8(1):37-42. PubMed ID: 11957118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.